CHICAGO, April 23, 2013 /PRNewswire/ -- Allscripts took another key step in delivering an Open, Connected Community of Health™ with the release of Allscripts Care Director™. The new solution ...

Allscripts is extending its partnership with Microsoft to use the tech giant's cloud technology to enhance its electronic health record (EHR) software. The new five-year strategic partnership will ...

Allscripts and Hospital IQ, a hospital performance management platform, have entered a strategic agreement in which Allscripts clients will have access to Hospital IQ’s predictive analytics platform.

CHICAGO & REDMOND, Wash.--(BUSINESS WIRE)--Today Allscripts (MDRX: NASDAQ) and Microsoft Corp. announced the extension of their long-standing strategic alliance to enable the expanded development and ...

Allscripts announced July 30 that Strata Decision Technology will acquire its healthcare decision analytics and budgeting business Epsi for $365 million. The transaction is expected to close later ...

Allscripts Healthcare Solutions Inc. MDRX recently announced that it has strengthened its strategic relationship with Pulse8, a leading player in healthcare analytics and technology. Earlier this ...

Allscripts announced on Thursday after stock markets closed that it is buying rival McKesson’s health IT unit. For $185 million in cash, Allscripts gains the product portfolio McKesson calls ...

Allscripts Healthcare Solutions' payer and life sciences division, Veradigm, has inked a contract with the Social Security Administration, the U.S. agency that administers Social Security retirement ...

Allscripts Healthcare Solutions (NASDAQ:MDRX), the healthcare technology company, has formally changed its name to Veradigm. Veradigm (MDRX) provides services to 300K US healthcare providers via the ...

Allscripts announced on Wednesday that it had entered into an agreement with Toronto-based Constellation Software's N. Harris Computer Corporation to acquire the net assets of the electronic health ...

Allscripts Healthcare Solutions on Thursday posted a nearly 7% rise in year-over-year second-quarter revenue as it continues to refocus its business on its payer and life sciences division, Veradigm.